In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Synovis wins bid for all Pegasus assets, pays $12.1mm cash

Executive Summary

After shutting down operations this past May because it couldn't raise more cash, privately held Pegasus Biologics has divested virtually all of its assets through a sealed bid auction to surgical device maker Synovis Life Technologies for $12.1mm in cash. Synovis will retain Pegasus' manufacturing facilities and fold the acquired IP into a newly created separate division.
Deal Industry
  • Biotechnology
  • Medical Devices
  • Medical Devices
    • Biomaterials
    • Implantable Devices
Deal Status
  • Final
Deal Type
  • Acquisition
    • Acquisition of Private Biotech
    • Full Acquisition
    • Intra-Biotech Deal
    • Payment Includes Cash

Related Companies